Top Markets
Coin of the day
Diffusion Pharmaceuticals Inc. Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals Inc.

DFFN
Rank in Stocks #31352
As a biopharmaceutical enterprise, Diffusion Pharmaceuticals Inc. concentrates... As a biopharmaceutical enterprise, Diffusion Pharmaceuticals Inc. concentrates on pioneering new treatments that bolster the body's efficiency in oxygen distribution. The company's flagship investigational therapy is Trans Sodium Crocetinate, which is formulated to facilitate the spread of oxygen into tissues. This compound is additionally under development for its application in addressing COVID-19. Headquartered in Charlottesville, Virginia, Diffusion Pharmaceuticals Inc. was established in 2001.
Share Price
$6.60
Last synced: 2023-08-16
Market Cap
$13.46M
Change (1 day)
11.68%
Change (1 year)
0.00%
Country
US
Trade Diffusion Pharmaceuticals Inc. (DFFN)

Category

Stock price history for Diffusion Pharmaceuticals Inc. (DFFN)
Highest end of day price: $5.14 on 2023-08-01

Lowest end of day price: $4.19K on 2016-11-01
Stock price history of Diffusion Pharmaceuticals Inc. from 2016 to 2026
Annual Stock Price Performance
Year Performance
2023 -41.85%
2022 -67.30%
2021 -51.58%
2020 68.95%
2019 -83.84%
2018 -86.17%
2017 -49.59%
2016 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$527.89 35.40%
US
$996.61 50.70%
NL
$111.31 -36.83%
AU
$735.86 6.87%
CH
$257.75 13.01%
BE